Grant Applications
As PI, co-PI, or Mentor
The contents of this site are for private use only and are not to be distributed or
reproduced without the express written consent of the copyright holders.
2023-February - National Institutes of Health/National Cancer Institute - "Is ERBB4 a driver of BRAF-WT melanomas" - 1R15CA280767-01A1 - Application
2023-January - Auburn University Research Support Program - "Is EGFR or ERBB2 Required for ERBB4 to Drive the Proliferation of BRAF WT Metastatic Melanomas" - Initial Review - Revised Application - Second-Tier Review - Not selected for funding
2022-June - National Institutes of Health/National Cancer Institute - "Is ERBB4 a driver of BRAF-WT melanomas" - 1R15CA280767-01 - Application - Supplemental Information - Review - Not selected for funding
2021-Nov - US Army Medical Research and Development Command CDMRP Melanoma Research Program - "Validation of the ERBB Signaling Network as a Target for Therapeutic Intervention in BRAF-WT Melanoma" - ME210378 - Application - Review - Initial Funding Decision - Final Funding Decision
2020-Jan - Auburn University Intramural Grant Program - "Targeted Melanoma Therapy: Identification of ERBB4 Melanoma Driver Mutants" - Application and Review (Zip file)
2019-Oct - US Army Medical Research and Development Command CDMRP Melanoma Research Program - "Identifying and Validating Metastatic Driver Mutations of ERBB4: Evaluating a Paradigm for Preventing and Targeting Metastatic Disease" - ME190139 - Application - Not selected for funding - Review
2018-Feb - National Institutes of Health/National Cancer Institute - "Preclinical cancer drug discovery training program" - F99CA234964 - Application - Not selected for funding - Review
2013-Dec - Lloyd Charitable Trust - "Discovery of Melanoma Chemotherapeutics That Target the ErbB4 RTK" - Application - Not selected for funding
2013-Nov - National Institutes of Health/National Cancer Institute - "Development of Assays for Chemotherapeutics Targeting the ErbB4 RTK" - R01CA175348 - Application - Not selected for funding
2013-Sep - US Army Medical Research and Materiel Command CDMRP Breast Cancer Research Program - "Exome Sequencing Breast Cancer Families From a Homogenous Population" - BC131426 - Not selected for funding
2013-Aug - Auburn University Research Initiative in Cancer (AURIC) - "Development of HTS Assays for ErbB4 Partial Agonists and Antagonists" - Not selected for funding
2012-Jul - National Science Foundation - 1250079 - "IGERT: Pharmaceutical Engineering" - Not selected for funding
2012-Jun - National Institutes of Health/National Cancer Institute - "Development of Screens for Probes and Chemotherapeutics That Target the ErbB4 RTK" - R01CA175348 - Application - Not selected for funding - Review
2012-Apr - US Army Medical Research and Materiel Command CDMRP Breast Cancer Research Program - "mAb-based ErbB4 antagonists: Functional probes and potential chemotherapeutics" - BC120345 - Application - Not selected for funding
2012-Jan - US Department of Education Graduate Assistance in the Areas of National Need (GAANN) - "Fellowships in Biological and Pharmaceutical Engineering" - Selected for funding
2011-Jun - US Army Medical Research and Materiel Command CDMRP Breast Cancer Research Program - "Canine Breast Cancers as Models for Human Disease" - BC110547 - Application - Not selected for funding
2011-Feb - Mary Kay Foundation - "Development and Validation of a Screening Strategy for a Novel Class of EGFR Inhibitors" - Application - Not selected for funding
2010-Oct - National Institutes of Health/National Cancer Institute - "Mapping Sites of Phosphorylation by ErbB Receptor Tyrosine Kinases" - R01CA161230 - Application - Not selected for funding - Review
2010-Oct - National Institutes of Health/National Cancer Institute - "Drug-sensitive EGF receptor mutants in lung cancer" - R01CA115830-06A1 - Application - Not selected for funding - Review
2010-May - Auburn University Internal Grants Program - "Validation of Canine Models for Human Breast Cancer" - Application - Selected for funding - Review
2010-Mar - US Army Medical Research and Materiel Command CDMRP Breast Cancer Research Program - "Novel Strategy for Mapping Biologically-Relevant Sites of Phosphorylation by ErbB Receptor Tyrosine Kinases" - BC101555 - Application part 1 - Application part 2 - Not selected for funding - Review